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Abstract
Background: Patient reported outcome measures (PROMs) have been introduced in studies to assess healthcare
performance. The development of PROMs for primary care poses specific challenges, including a preference for
generic measures that can be used across diseases, including early phases or mild conditions. This pilot study
aimed to explore the potential usefulness of seven generic measures for assessing health outcomes in primary care
patients.
Methods: A total of 300 patients in three general practices were invited to participate in the study, shortly after
their visit to the general practitioner. Patients received a written questionnaire, containing seven validated
instruments, focused on patient empowerment (PAM-13 or EC-17), quality of life (EQ-5D or SF-12), mental health
(GHQ-12), enablement (PEI) and perceived treatment effect (GPE). Furthermore, questions on non-specific symptoms
and number of GP contacts were included. After 4 weeks patients received a second, identical, questionnaire.
Response and missing items, total scores and dispersion, responsiveness, and associations between instruments and
other measures were examined.
Results: A total of 124 patients completed the questionnaire at baseline, of whom 98 completed it both at baseline
and 4 weeks later (response rate: 32.7%). The instruments had a full completion rate of 80% or higher. Differences
between baseline and follow up were significant for the EQ-5D (p = 0.026), SF-12 PCS (p = 0.026) and the GPE
(p = 0.006). A strong correlation (r ≥ 0.6) was found between the SF-12 MCS and GHQ-12, at both baseline
measurement and after four weeks. Other observed associations between instruments were moderately strong. No
strong correlations were found between instruments and non-specific symptoms or number of GP contacts.
Conclusions: The present study is among the first to explore the use of generic patient-reported outcome
measures in primary care. It provides several leads for developing a generic PROM questionnaire in primary care as
well as for potential limitations of such instruments.
Keywords: Patient-reported outcome measures, Primary care, General practice, Quality of life, Patient
empowerment, Patient enablement
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Background
Patient reported outcome measures (PROMs) are stan-
dardised, validated questionnaires that are completed by
patients to measure perceived health status, functional
status or health-related quality of life [1]. While PROMs
are used in health research to document health out-
comes, in particular treatment effectiveness in clinical
trials [2], today they are also used to measure healthcare
quality. For instance, in 2009 the National Health System
in the UK started to use PROMs to assess the quality of
four elective procedures [3]. The adoption of PROMs in
primary care, however, poses specific challenges that are
related to the specific characteristics of their patient
population. Primary care patients show a wide range of
diseases, including many early undifferentiated stages
and mild conditions. Furthermore, primary care provides
comprehensive and continuing healthcare [4]. From the
WONCA competencies and corresponding characteristics
of general practice follow some other domains that can be
measured at the patient level and may be appropriate as
outcome measures. These are that the general practitioner
should “develop a person centred approach orientated to
the individual, his/her family, their community, where it as
important to understand how the patient copes with and
views their illness as dealing with the disease process it-
self”; and that the general practitioner should “promote
patient empowerment” [4]. Scales measuring patient en-
ablement and patient empowerment may be appropriate
to measure these domains. When developing PROMs for
primary care these factors should be taken into account,
implying that generic measures that can be used across
diseases are preferable to disease-specific measures, and
that a broad set of domains of general practice should be
addressed by a PROM.
Many questionnaires exist that aim to assess primary
care performance from the patients’ perspective. For in-
stance, the Primary Care Assessment Survey (PCAS) stud-
ies seven domains of general practice, such as accessibility,
continuity, comprehensiveness and interpersonal treat-
ment [5]. The European Task Force on Patient Evaluations
of General Practice (EUROPEP) measures patient evalua-
tions of a broad range of specific aspects of general prac-
tice care, such as showing interest, involving the patient in
decision making and thoroughness [6], and the Patient As-
sessment of Chronic Illness Care (PACIC) studies chronic
care delivery [7]. Most existing questionnaires for asses-
sing primary care performance, however, focus on the or-
ganisation and process of healthcare delivery, instead of
care outcomes.
Some validated questionnaires for functional status or
quality of life, which were not primarily developed for
primary care performance measurement, may be good
options for PROMs in primary care. Before embarking on
the development of a new tool, we explored a number of
existing measures that focus on these domains in a pilot
study. Besides its generic character, we felt that a poten-
tially useful PROM should have high relevance for primary
care patients (indicated by good response rates), have po-
tential to discriminate between care providers (indicated
by absence of highly skewed distributions), show respon-
siveness to change of patients’ symptoms over time, and
be predictably correlated with other measures. Based on
these predefined criteria, we aimed to explore the poten-
tial usefulness of seven generic patient reported outcome
measures in primary care. The results of this pilot study
can possibly be used to inform further research and devel-
opment of PROMs in primary care as well as for reflection
on the potential limitations of PROMs in primary care.
Methods
Design and setting
An observational study was performed in patients who
visited their general practitioner for consultation in one
of three participating practices (five general practitioners
in total). A maximum of 60 patients per general practi-
tioner was invited to minimize workload for general prac-
titioners. Practices were situated in the south-eastern part
of The Netherlands, and concerned one practice in an
urban area and two in a rural area. One practice was
single-handed and two were group practices. Ethical ap-
proval was received for this study from the Arnhem-
Nijmegen ethical committee.
Study population
A total of 300 patients was invited who visited one of
the participating general practitioners for a consultation.
Patients were not invited to participate if they were
younger than 18 years old, terminally ill, or had psycho-
logical problems or a mental handicap as a result of which
the GP estimated the patient was not suitable to partici-
pate in research at the moment. Written questionnaires
were handed out by the general practitioner during the
consultation. Patients were asked to complete the ques-
tionnaire and return it to the research institute in a pre-
paid envelope. In the questionnaire, patients were asked if
they were willing to complete a second identical question-
naire after 4 weeks. If so, patients were sent a second
questionnaire by the research institute.
Measures
We performed a comprehensive search in PubMed using
keywords primary care and patient reported outcomes.
We scanned articles and references of relevant articles
for existing questionnaires on the outcome domains listed
in Table 1. Furthermore, we consulted colleagues to iden-
tify instruments they had previously used. We searched
the internet for a Dutch translation of questionnaires, and
only included questionnaires that were available in Dutch.
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For some domains multiple questionnaires were found.
We excluded questionnaires on the basis of length. The
selected questionnaires are listed in Table 2, and are fur-
ther elucidated on in the paragraphs below. Excluded
questionnaires included the Measure Yourself Medical
Outcome Profile (MYMOP) [8] and the Outcome Related
Impact on Daily Life (ORIDL) [9] for unavailability of a
Dutch translation, and the Sickness Impact Profile (SIP)
[10] due to its length. Furthermore, the Spielberger State-
Trait Anxiety Inventory (STAI) [11] was not included
since it focuses specifically on anxiety. We chose to in-
clude generic instruments focusing on mental health,
thereby limiting the total length of our questionnaire.
Finally, we included a Global Perceived Effect scale
(GPE) for assessing the effect of received care.
The Patient Activation Measure (PAM-13) and the Ef-
fective Consumer Scale (EC-17) were alternately used to
measure patient empowerment. The PAM-13 consists
of 13 items that evaluates a patient’s knowledge, skills
and confidence to manage their own health [12]. Item
scores are converted in one activation score, reflecting a
patient’s activation level. Missing values are accounted
for in calculation of the total score. The EC-17 consists
of 17 items on 5 subscales (use of health information,
clarifying priorities, communication with others, negoti-
ating own role, and taking action) [13]. Item scores are
converted to a score on a 0-100 scale. If more than 3
items are missing no total score is computed. Because
the EC-17 specified having a disease in its questions, we
added a not applicable response option, which we treated
as missing data in computing the total score.
The EuroQol-5D (EQ-5D) and the Short Form 12
(SF-12) were alternately used to measure quality of life.
The EQ-5D consists of five dimensions (mobility, self-care,
usual activities, pain/discomfort and anxiety/depression)
with three response categories (no problems, some
problems, extreme problems) [14]. Total score was cal-
culated using Dutch population norms [15]. Further-
more, the EQ-5D contains a visual analogue scale (VAS)
on which respondents score their current health status
on a scale from 0 to 100. The SF-12 is a 12-item ques-
tionnaire measuring eight domains: physical function-
ing, role-physical, bodily pain, general health, vitality,
social functioning, role-emotional and mental health [16].
Each item is scored on a 3- or 5-point Likert scale, and for
each domain a total score is computed on a 0-100 scale.
With these item scores, a physical component summary
(PCS) and a mental component summary (MCS) can be
calculated.
The General Health Questionnaire (GHQ-12) was used
to measure mental health. It consists of 12 items, each
with a 4-point response category (from ‘better than usual’
to ‘much less than usual’) [17], in which each item receives
a score of 0, 1, 2 or 3. The total score for the GHQ-12 thus
ranges from 0 to 36, where a lower score reflects better
mental health.
The Patient Enablement Instrument (PEI) was used to
measure patient enablement [18]. It consists of six items,
each with three response categories (0 = ‘same or worse’,
1 = ‘better’, 2 = ‘much better’). The range of the aggregated
sum score is 0 to 12, with a higher score indicating a
higher level of enablement.
A Global Perceived Effect (GPE) scale was used to
measure perceived effect of treatment. The scale consists
of one item that asks patients about perceived effect of
treatment [19]. Patients score on a seven point response
scale (with 1 = ‘worse than ever’, 7 = ‘fully recovered’). Fur-
thermore, we dichotomized the GPE scores into “im-
proved” (“completely recovered” and “much improved”)
versus “not improved” (“slightly improved”, “not changed”,
“slightly worsened”, “much worsened”, “worse than ever”),
and added a question about treatment satisfaction (also on
a seven-point scale).
The questionnaire also included questions about non-
specific symptoms and the number of GP contacts in the
previous 12 months. Non-specific symptoms included fa-
tigue, dizziness, headache, weakness, palpitation and sleep
problems, and their presence can indicate underlying
changes in emotional well-being [20]. As said, some in-
struments that aimed to measure the same domain were
used alternately to reduce length. Therefore, a total of four
versions of the questionnaire were used.
Table 1 Possible outcome domains for PROMS following from the WONCA definition of general practice
WONCA competency WONCA characteristics Possible outcome domain
Comprehensive approach Promotes health and well-being General-, physical and mental health
Person-centred care Promotes patient empowerment Patient empowerment
Centred on patient and context Patient enablement
Table 2 Domains and used questionnaires
Domain Questionnaire
Patient Empowerment Patient Activation Measure (PAM-13)
Effective Consumer Scale (EC-17)
General Health EuroQol 5D (EQ-5D, including EQ-VAS)
Short Form 12 (SF-12)
Mental Health General Health Questionnaire (GHQ-12)
Enablement Patient Enablement Instrument (PEI)
Effect Global Perceived Effect (GPE)
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Sample size calculation
For our explorative study, no figures were available for a
proper power calculation given the new context of the
questionnaires distributed. We based our sample size
largely on what number of questionnaires would be feas-
ible in terms of burden for the recruiting GPs and what
sample size would give a meaningful precision. Therefore,
we invited a total of 300 patients (60 per GP). We ex-
pected a response rate of approximately 50%, resulting in
all instruments having a response of 150 patients or 75 pa-
tients (in case of the EQ-5D, SF-12, PAM-13 and EC-17).
This results in a precision (half width of the 95%-CI for
mean difference) of 4.8 and 3.5 points (assuming a 100
points scale with a SD of at most 15), which seemed suffi-
ciently precise to detect non-small differences [21].
Data-analysis
We first studied the response on individual instruments,
and the missing values on items. Instruments with a low
response or a high number of missing scores were consid-
ered less appropriate for potential use in practice.
Secondly, we studied statistical dispersion of scores for
each of the instruments, exploring mean, minimum and
maximum scores and standard deviations. We examined
if data was normally distributed by exploring histograms
and using the Shapiro-Wilk test. Furthermore, we studied
floor and ceiling effects in terms of percentage of patients
using the most extreme (upper or lower) response cat-
egories. Instruments with a squeezed distribution, or high
presence of floor and ceiling effects were thought to be
less appropriate for potential use in practice.
Responsiveness has been defined as the ability of an
instrument to accurately detect change when it has oc-
curred [22]. Change in instrument scores between baseline
and follow-up were explored, and were tested on signifi-
cance with a paired samples t-test or in case of a skewed
distribution with a Wilcoxon signed-rank test. We ex-
plored changes in scores between baseline and follow up,
where positive changes could reflect the relief of com-
plaints at baseline due to treatment or favourable natural
development. Furthermore, we used Pearson correlation
to identify moderate (r = .40-.59), strong (r = .60-.79) and
very strong associations (r = .80 = 1.0) between instrument
scores [23]. We explored if scores of instruments focusing
on the same domains correlated.
Finally, we looked at treatment satisfaction, presence
of non-specific symptoms and number of contacts with
the GP to assess construct validity. Construct validity
refers to the extent to which scores on a particular in-
strument relate to other measures in a manner that is
consistent with theoretically derived hypotheses con-
cerning the concepts that are being measured [24,25].
We expected that treatment satisfaction would be posi-
tively correlated with instruments scores [26], while the
presence of non-specific symptoms was expected to
have a negative correlation with instrument scores [20].
Furthermore, we explored if visiting frequency was associ-
ated with instruments scores. Since all seven instruments
had previously been validated in other contexts, we ex-
pected that content validity was assured.
Finally, an a posteriori sample size calculation was per-
formed to learn about the number of questionnaires
needed to show a meaningful difference.
Results
Of 300 invited patients, 124 completed the questionnaire
at baseline and 98 patients completed the questionnaire
both at baseline and after 4 weeks (response rate: 32.7%).
Response percentages ranged from 16.7% to 50.0% across
the participating general practitioners. Table 3 provides
descriptive information of the study population. In com-
parison with Dutch GP population, our study population
was less ethnically diverse and more likely to have one or
more chronic illnesses [27]. Most prevalent chronic ill-
nesses were cardiovascular disease (31.6%), diabetes
(15.3%) and depressive symptoms (11.2%). 56% of patients
with a chronic illness used medication.
Response and missing items
Response percentages and the number of missing items
on the individual instruments are presented in Table 4.
The response on the different instruments ranged from
87.5% to 99.0%. Of each instrument, over 80% was com-
pleted without any missing items. The EC-17 had a rela-
tively high number of missing values. The response on
the EC-17 was 91.8%, but because we treated the not
applicable response option as missing and no total
score was computed with more than 3 missing items, a
total of 36 scores remained (73.5%).
Dispersion
The median, minimum and maximum scores, as well as
inter-quartile ranges (IQR) at baseline and after four
weeks are presented in Table 5. Floor and ceiling effects
for the specific measures are provided in Table 6. In
comparison to other instruments, the EQ-5D had a high
Table 3 Patients’ characteristics (n = 98)
Study population
Mean age (SD) 62.5 (12.2)
Percentage women 44.2%
Percentage with higher education 34.7%
Percentage with single household 18.3%
Percentage of Dutch decent 99.0%
Percentage with one or more chronic illnesses 55.1%a
aIncluded asthma, cardiovascular disease, COPD, depression and diabetes.
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prevalence of maximum scores and the PEI had a high
prevalence of minimum scores.
Responsiveness
All measures showed increased mean scores over time,
indicating improvement in health status, though for most
instruments no median score differences were observed.
The differences in mean scores between baseline and
follow up at four weeks were significant for the EQ-5D
(p = 0.026), SF-12 PCS (p = 0.026) and the GPE (p =
0.006). When looking at dichotomous scores of the GPE,
we found that 15 out of 89 patients at baseline right after
the consultation, and 27 out of 89 patients after four
weeks indicated to have improved after their visit to the
GP. A total of 18 patients improved after four weeks in re-
lation to baseline, while 6 patients worsened in these four
weeks. Table 7 presents the percentage of patients that
had an increased or worsened score for the specific mea-
sures. In comparison to other measures, the EQ-5D and
PEI showed little change across time with approximately
half of the patients having the same score at follow-up.
Associations between instruments
For baseline scores, strong associations were found be-
tween the SF-12 MCS and the GHQ (r = -0.768, p =
0.000), and the EQ-5D en EQ-VAS (r = 0.604, p = 0.000).
Moderate associations were found between the PAM-13
and EQ-5D (r = 0.409, p = 0.043), the PAM-13 and SF-12
MCS (r = 0.438, p = 0.079), and the EQ-VAS and GPE (r =
0.429, p = 0.004). For scores after four weeks, strong asso-
ciations were found between the EC-17 and EQ-VAS (r =
0.709, p = 0.010), EQ-VAS and GPE (r = 0.661, p = 0.000),
the GHQ and SF-12 MCS (r = -0.705, p = 0.000), and the
GHQ and EQ-VAS (r = -0.633, p = 0.000). Moderate asso-
ciations were found between the PAM-13 and EQ-5D (r =
0.440, p = 0.028), PAM-13 and EQ-VAS (r = 0.552, p =
0.003), PAM-13 and GPE (r = 0.481, p = 0.001), EQ-5D
and EQ-VAS (r = 0.568, p = 0.000), EQ-5D and GPE (r =
0.542, p = 0.000), EC-17 and GHQ (r = -0.492, p = 0.002),
GHQ and SF-12 PCS (r = -0.420, p = 0.006). When looking
at change of scores on the instruments, strong associations
were found between the EC-17 and EQ-VAS (r = 0.554,
p = 0.061), SF-12 PCS and SF-12 MCS (r = -0.523, p =
Table 4 Response on individual measures
Number
of items
Completed at baseline
and after 4 weeks (n)
Baseline measurement After 4 weeks
0 missing 1 missing 2 missing ≥3 missing 0 missing 1 missing 2 missing ≥3 missing
PAM-13 13 95.9% (47/49) 43 4 - - 45 2 - -
EC-17a 17 91.8% (45/49) 43 1 1 - 39 5 1 -
EQ-5D 5 94.0% (45/50) 42 3 - - 43 2 - -
EQ- VASb 1 94.0% (47/50) 47 47
SF-12 12 87.5% (42/48) 42 - - - 42 - - -
GHQ-12 12 99.0% (97/98) 94 2 1 - 94 3 - -
PEI 6 99.0% (97/98) 94 1 - 2 92 - 2 3
GPEb 1 90.8% (89/98) 89 89
aIf 3 or more items were missing or not applicable no total score was computed; 36 total scores computed (73.5%).
bInstrument consists of 1 item.
Table 5 Total scores and change of scores on individual measures (n = 98)
Baseline score Score after four weeks Score difference
Instrument (n) Theoretical
range of scale
Median Min. Max. IQR Median Min. Max. IQR Median Min. Max. IQR
PAM-13 (47) 0 - 100 56.4 41.7 100.0 49.9 - 70.8 56.4 40.1 100.0 49.9 - 70.8 0.0 −43.6 38.9 −2.8 to 6.7
EC-17 (36)a 0 - 100 76.5 55.9 100.0 75.0 - 83.8 80.3 63.2 98.5 75.0 - 88.1 0.0 −10.9 36.8 −2.4 to 4.4
EQ-5D (45) 0 - 1 0.84 0.15 1.00 0.79 - 0.89 0.84 0.25 1.00 0.81 - 1.0 0.00c −0.44 0.28 0.00 to 0.11
EQ- VAS (47) 0 - 100 70.0 30 100 60.0 - 80.0 75.0 40 100 70.0 - 80.0 0.0 −25.0 20.0 −5.0 to 10.0
SF-12 PCS (42) 0 - 100 42.3 18.7 60.5 32.4 - 53.5 49.8 17.8 58.9 37.5 - 54.4 2.0c −15.3 28.8 −1.3 to 7.1
SF-12 MCS (42) 0 - 100 56.0 17.3 65.8 48.7 - 59.0 54.1 19.8 62.7 49.3 - 58.9 0.0 −25.8 20.9 −6.3 to 4.4
GHQ-12 (97) 0 - 36b 9.0 3.0 26.0 7.0 - 13.0 8.0 3.0 25.0 7.0 - 12.0 0.0 −13.0 10.0 −2.0 to 2.0
PEI (97) 0 - 12 0.0 0.0 6.0 0.0 - 2.5 0.0 0.0 12.0 0.0 - 2.0 0.0 −6.0 8.0 −0.5 to 0.0
GPE (89) 1 - 7 4.0 2 7 4.0 - 5.0 4.0 3 7 4.0 - 6.0 0.0 c −3.0 3.0 0.0 to 1.0
aIf 3 or more items missing then no score was computed.
bLower score means better health.
cMean score difference significant with p ≤ 0.05.
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0.000), and GHQ and SF-12 MCS (r = -0.530, p = 0.000).
A moderate association was found between the EQ-5D
and EQ-VAS (r = 0.438, p = 0.003).
Associations with other measures
At baseline, a total of 77 out of 91 patients reported to
be very or absolutely satisfied with treatment (84.6%). At
follow-up this was 69 patients (75.9%). A moderate posi-
tive correlation was found between treatment satisfaction
and the EC-17 (r = 0.490, p = 0.003) at baseline. At follow-
up, a strong correlation was found between treatment
satisfaction and the SF-12 PCS (r = 0.575, p = 0.000). No
other significant correlations were found.
At baseline, 69.4% of the patients reported to have suf-
fered from one or more non-specific symptoms in the past
four weeks. These included fatigue (57.3%), headache
(36.0%) and sleep problems (34.8%). After four weeks this
was 70.4%, with fatigue (53.9%), headache (37.5%) and
sleep problems (26.4%) most often mentioned. A total of
59 patients (60.2%) indicated at both measure moments to
have suffered from one or more non-specific symptoms in
the past four weeks. A moderate negative association was
found between the presence of non-specific systems and
the SF-12 PCS score (r = -0.424, p = 0.005) after four
weeks, though at baseline no significant association was
found (r = -0.272, p = 0.082).
The mean number of reported GP contacts in the past
12 months was 6.9 at baseline. At follow-up, patients re-
ported to have had an average of 1.3 GP contacts in the
four weeks between baseline and follow-up. No correla-
tions were found between the number of GP contacts and
instrument scores.
Number of questionnaires needed
Most instruments in our study had a SD between 10-15%
of the instruments’ range, resulting in a required sample
size of N = 400 to detect small differences between base-
line and after four weeks [21].
Discussion
We found high completion rates for all seven instruments,
with only a small number of items missing. Total scores
for the instruments varied across patients, with the EQ-5D
and PEI having a relatively high prevalence of maximum
and minimum scores respectively, and most instruments
being susceptible for change in the period between baseline
and after four weeks. Some strong associations were found
between the seven instruments, and between instruments
and other measures such as treatment satisfaction and
non-specific symptoms, but overall correlations tended to
be weak or moderate. Based on our predefined criteria
none of the seven instruments seem to stand out in a posi-
tive or negative way, and their potential use as PROMs
should be studied more elaborately. Finally, the low re-
sponse rate needs to be considered if PROMs are used in
performance measurement systems, because this could
lead to selection bias.
Our study is one of the first to explore the use of gen-
eric patient-reported outcome measures in primary care.
In the US, the Patient-Reported Outcome Measurement
Information Systems (PROMIS) aims at the continuing
development of patient-reported measures that are com-
parable across studies and diseases [28]. These measures
focus on the domains physical-, mental- and social
Table 6 Floor and ceiling effects
Instrument (n) Minimum score baseline Maximum score baseline Minimum score follow up Maximum score follow up
PAM-13 (47) 0.0% (0/47) 2.1% (1/47) 0.0% (0/47) 2.1% (1/47)
EC-17 (36) 0.0% (0/36) 2.8% (1/36) 0.0% (0/36) 0.0% (0/36)
EQ-5D (45) 0.0% (0/45) 22.2% (10/45) 0.0% (0/45) 44.4% (20/45)
EQ- VAS (47) 0.0% (0/47) 2.1% (1/47) 0.0% (0/47) 6.4% (3/47)
SF-12 PCS (42) 0.0% (0/42) 0.0% (0/42) 0.0% (0/42) 0.0% (0/42)
SF-12 MCS (42) 0.0% (0/42) 0.0% (0/42) 0.0% (0/42) 0.0% (0/42)
GHQ-12 (97) 0.0% (0/97) 0.0% (0/97) 0.0% (0/97) 0.0% (0/97)
PEI (97) 54.6% (53/97) 0.0% (0/97) 60.8% (59/97) 1.0% (1/97)
GPE (89) 1.1% (1/89) 5.6% (5/89) 0.0% (0/89) 6.7% (6/89)
Table 7 Improved scores on individual measures
(% of patients)
Instrument (n) Improved score Same score Worsened score
PAM-13 (47) 46.8% 14.9% 38.3%
EC-17 (36) 47.2% 19.4% 33.3%
EQ-5D (45) 40.0% 46.7% 13.3%
EQ- VAS (47) 48.9% 21.3% 29.8%
SF-12 PCS (42) 57.1% 7.1% 35.7%
SF-12 MCS (42) 47.6% 7.1% 45.2%
GHQ-12 (97)a 47.4% 11.3% 41.2%
PEI (97) 22.7% 52.6% 24.7%
GPE (89) 41.6% 37.1% 21.3%
aLower total score on the GHQ reflects improved score.
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health, and in the current literature on PROMs we also
see a focus on quality of life. The present study adds that
it explores a broad set of outcome domains (i.e. empower-
ment, mental health, physical health, general health, en-
ablement and perceived treatment outcome) that all seem
to be of importance in primary care.
The present study had a low response compared to re-
cent studies conducted in Dutch general practice [29,30].
This low response may indicate selection bias, making it
uncertain whether the sample reflected the general prac-
tice population. If such a measure were to be used as a
performance measure, a low response would have its im-
plications on interpreting the data. In our study we did
not send a reminder, because we obtained patients’ contact
information only after their return of the baseline ques-
tionnaire. One potential explanation for the low response
rate is the length of the questionnaire. Shortening the
measure might result in an increased response in future
studies, as has been demonstrated in previous studies [31].
The relatively small size of the study limited the possibility
to detect small differences in time or between groups of
patients, and significant associations between instruments
and other measures. This makes it hard to draw firm con-
clusions from this study regarding the seven instruments,
and replication in larger studies is required with a sample
size of at least 400 patients. Despite these limitations, the
study provided a number of important leads to the further
development of PROMs for adoption in primary care.
Ideally, PROMs are measured before and after a specific
intervention. In general practice, however, it is often diffi-
cult to determine a clear start and endpoint of treatment.
In this study we had two measure moments, both after the
consultation with the physician. Therefore the change
may reflect effectiveness of interventions, natural course
of symptoms, or measurement error. Because continuity
of care is one of the hallmarks of general practice, inter-
ventions are not limited to one episode of care but cover
patient’ health needs longitudinally [4,32]. The data there-
fore could still express performance of general practice.
Further research is needed to determine if other measure
moments than those used in the present study are
favourable in primary care.
The seven included instruments were frequently subject
of study in previous research, though only limited as
outcome measures in the setting of a generic population
in general practice.
In our study we found a low responsiveness to change
of the EQ-5D, also reflected by a high prevalence of
maximum scores at both baseline and after four weeks.
Previous studies showed ambiguous results regarding re-
sponsiveness of the EQ-5D [33,34]. This might be ex-
plained by the different settings in which these studies
took place. Our findings suggest that for a generic popu-
lation visiting the GP other instruments that measure
quality of life such as the SF-12 might be more appropri-
ate, though no firm conclusions can be drawn.
The EC-17 specifically focuses on measuring main
skills and behaviours needed to effectively manage ones
chronic disease. Some of the items of the EC-17 are ex-
plicitly targeted at the patients’ disease. This resulted in
a relatively low number of applicable answers on this
instrument, since not all patients in our study popula-
tion had a disease. The PAM-13 also focuses on chronic
patients, though items are targeted at the patients’
health instead of the patients’ disease, which might ex-
plain why this instrument resulted in a higher response
rate. This might opt for including the PAM-13 for
measuring empowerment, though its validation for a
general population in the primary care setting needs be
studied.
Previous research that studied the outcome of patient
consultations found associations between some of the
used instruments and other measures, such as the PEI
and the patients’ health status [35] and the PEI and
treatment satisfaction [18], showed ambiguous results
regarding the relation between health status and treat-
ment satisfaction [26,36], and related the presence of
non-specific symptoms to emotional distress [20]. In
our study we only found a few strong associations, such
as that between the GHQ and SF-12 MCS scores, which
was to be expected since they both measure mental
health, and between treatment satisfaction and the
physical component scale of the SF-12. No other strong
associations were found between instruments, or with
other measures.
This study is to our knowledge one of the first that
studies several previously validated questionnaires on
different domains as potential PROMs in primary care.
It may be used in the further exploration of adapting
PROMs in general practice, though our findings are
only preliminary results and further research is needed.
We think that embedding a short informative measure
in the care delivery process where it acts as a feedback
tool on the patients’ level brings along opportunities.
This way the added value for both GP and patient is
clear, and it is easier for the GP to act upon this feed-
back in daily practice if needed. On the other side, em-
bedding PROMs in the care process increases workload
for the GP, which needs to be taken into consideration.
The potential use of the used instruments as an individ-
ual feedback tool in the primary care setting should be
studied more elaborately as well. Further research is
needed to determine the psychometric properties of
previously validated instruments in the current setting
of study (i.e. generic primary health care population).
Finally, the relation between the studied instruments
with relevant clinical measures and the quality of delivered
care is a point of interest for future studies.
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Conclusions
This study showed that several generic instruments on
the domains of quality of life, patient empowerment and
patient enablement might be fit for use as a PROM in
primary care, though further research is needed to study
their validity in primary care.
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